The PBRS-high group exhibited enhanced activation of cell proliferation-related pathways, such as E2F targets, G2M checkpoint, and MYC targets, along with upregulation of PI3K-AKT-mTOR signaling and oxidative phosphorylation, indicating a highly proliferative and metabolically active tumor phenotype. The gene discussed is AKT1; the disease is neoplasm.